Skip to main content

Open Access Pediatric delamanid treatment for children with rifampicin-resistant TB

Download Article:

No Abstract

Document Type: Letter to the Editor

Affiliations: 1: Médecins Sans Frontières, Khayelitsha, Cape Town, South Africa 2: Department of Health, Province of the Western Cape, Cape Town, South Africa 3: Department of Health, City of Cape Town, Cape Town, South Africa 4: Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA 5: The Sentinel Project on Pediatric Drug Resistant Tuberculosis, Boston, MA, USA 6: Institute of Infectious Diseases and Molecular Medicine, Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa

Publication date: October 1, 2022

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content